|
1
|
Morice P, Leary A and Gouy S: Mucinous
ovarian carcinoma. Reply. N Engl J Med. 381:e32019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Trabert B, DeSantis CE, Miller
KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A and Siegel RL:
Ovarian cancer statistics, 2018. CA Cancer J Clin. 68:284–296.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cortez AJ, Tudrej P, Kujawa KA and
Lisowska KM: Advances in ovarian cancer therapy. Cancer Chemother
Pharmacol. 81:17–38. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cancer Facts Figures 2018, . American
Cancer Society; Atlanta, GA: 2018
|
|
5
|
Mallen AR, Townsend MK and Tworoger SS:
Risk factors for ovarian carcinoma. Hematol Oncol Clin North Am.
32:891–902. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wei W, Li N, Sun Y, Li B, Xu L and Wu L:
Clinical outcome and prognostic factors of patients with
early-stage epithelial ovarian cancer. Oncotarget. 8:23862–23870.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gulec UK, Gumurdulu D, Guzel AB, Paydas S,
Seydaoglu G, Acikalin A, Khatib G, Zeren H, Vardar MA and Altintas
A: Prognostic importance of survivin, Ki-67, and topoisomerase IIα
in ovarian carcinoma. Arch Gynecol Obstet. 289:393–398. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Szajnik M, Czystowska-Kuźmicz M, Elishaev
E and Whiteside TL: Biological markers of prognosis, response to
therapy and outcome in ovarian carcinoma. Expert Rev Mol Diagn.
16:811–826. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wade K, Brady MF, Thai T, Wang Y, Zheng B,
Salani R, Tewari KS, Gray HJ, Bakkum-Gamez JN, Burger RA, et al:
Measurements of adiposity as prognostic biomarkers for survival
with anti-angiogenic treatment in epithelial ovarian cancer: An NRG
oncology/gynecologic oncology group ancillary data analysis of GOG
218. Gynecol Oncol. 155:69–74. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Z, Meng Z, Jia L and Cui R: The tumor
microenvironment and cancer. Biomed Res Int. 2014:5739472014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feig C, Gopinathan A, Neesse A, Chan DS,
Cook N and Tuveson DA: The pancreas cancer microenvironment. Clin
Cancer Res. 18:4266–4276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Casey SC, Amedei A, Aquilano K, Azmi AS,
Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR,
et al: Cancer prevention and therapy through the modulation of the
tumor microenvironment. Semin Cancer Biol. 35 (Suppl):S199–S223.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pearce O, Delaine-Smith RM, Maniati E,
Nichols S, Wang J, Böhm S, Rajeeve V, Ullah D, Chakravarty P, Jones
RR, et al: Deconstruction of a metastatic tumor microenvironment
reveals a common matrix response in human cancers. Cancer Discov.
8:304–319. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoshihara K, Shahmoradgoli M, Martínez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia D, Li S, Li D, Xue H, Yang D and Liu
Y: Mining TCGA database for genes of prognostic value in
glioblastoma microenvironment. Aging (Albany NY). 10:592–605. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang DW, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoshihara K, Tsunoda T, Shigemizu D,
Fujiwara H, Hatae M, Fujiwara H, Masuzaki H, Katabuchi H, Kawakami
Y, Okamoto A, et al: High-risk ovarian cancer based on 126-gene
expression signature is uniquely characterized by downregulation of
antigen presentation pathway. Clin Cancer Res. 18:1374–1385. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heublein S, Mayr D, Friese K,
Jarrin-Franco MC, Lenhard M, Mayerhofer A and Jeschke U: The
G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian
granulosa cell tumors. Int J Mol Sci. 15:15161–15172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dorsam RT and Gutkind JS:
G-protein-coupled receptors and cancer. Nat Rev Cancer. 7:79–94.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Q, Madden NE, Wong A, Chow B and Lee
L: The role of endocrine G protein-coupled receptors in ovarian
cancer progression. Front Endocrinol (Lausanne). 8:662017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zeppernick F and Meinhold-Heerlein I: The
new FIGO staging system for ovarian, fallopian tube, and primary
peritoneal cancer. Arch Gynecol Obstet. 290:839–842. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rosendahl M, Hogdall CK and Mosgaard BJ:
Restaging and survival analysis of 4036 ovarian cancer patients
according to the 2013 FIGO classification for ovarian, fallopian
tube, and primary peritoneal cancer. Int J Gynecol Cancer.
26:680–687. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jelovac D and Armstrong DK: Recent
progress in the diagnosis and treatment of ovarian cancer. CA
Cancer J Clin. 61:183–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Au KK, Josahkian JA, Francis JA, Squire JA
and Koti M: Current state of biomarkers in ovarian cancer
prognosis. Future Oncol. 11:3187–3195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carlton JG, Jones H and Eggert US:
Membrane and organelle dynamics during cell division. Nat Rev Mol
Cell Biol. 21:151–166. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakamura K, Sawada K, Kobayashi M,
Miyamoto M, Shimizu A, Yamamoto M, Kinose Y and Kimura T: Role of
the exosome in ovarian cancer progression and its potential as a
therapeutic target. Cancers (Basel). 11:11472019. View Article : Google Scholar
|
|
28
|
Cheng L, Wu S, Zhang K, Qing YA and Xu T:
A comprehensive overview of exosomes in ovarian cancer: Emerging
biomarkers and therapeutic strategies. J Ovarian Res. 10:732017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Predescu DV, Crețoiu SM, Crețoiu D,
Pavelescu LA, Suciu N, Radu BM and Voinea SC: G protein-coupled
receptors (GPCRs)-mediated calcium signaling in ovarian cancer:
Focus on GPCRs activated by neurotransmitters and inflammation-
associated molecules. Int J Mol Sci. 20:55682019. View Article : Google Scholar
|
|
30
|
Albrecht H and Kübler E: Systematic
meta-analysis identifies co-expressed kinases and GPCRs in ovarian
cancer tissues revealing a potential for targeted kinase inhibitor
delivery. Pharmaceutics. 11:4542019. View Article : Google Scholar
|
|
31
|
Nayak AP and Penn RB: The proton-sensing
receptor ovarian cancer G-protein coupled receptor 1 (OGR1) in
airway physiology and disease. Curr Opin Pharmacol. 51:1–10. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nayak AP, Pera T, Deshpande DA, Michael
JV, Liberato JR, Pan S, Tompkins E, Morelli HP, Yi R, Wang N and
Penn RB: Regulation of ovarian cancer G protein-coupled receptor-1
expression and signaling. Am J Physiol Lung Cell Mol Physiol.
316:L894–L902. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Escobar J, Klimowicz AC, Dean M, Chu P,
Nation JG, Nelson GS, Ghatage P, Kalloger SE and Köbel M:
Quantification of ER/PR expression in ovarian low-grade serous
carcinoma. Gynecol Oncol. 128:371–376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Revinski DR, Zaragosi LE, Boutin C,
Ruiz-Garcia S, Deprez M, Thomé V, Rosnet O, Gay AS, Mercey O,
Paquet A, et al: CDC20B is required for deuterosome-mediated
centriole production in multiciliated cells. Nat Commun.
9:46682018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cheng S, Castillo V and Sliva D: CDC20
associated with cancer metastasis and novel mushroomderived CDC20
inhibitors with antimetastatic activity. Int J Oncol. 54:2250–2256.
2019.PubMed/NCBI
|
|
36
|
Kienesberger PC, Oberer M, Lass A and
Zechner R: Mammalian patatin domain containing proteins: A family
with diverse lipolytic activities involved in multiple biological
functions. J Lipid Res. 50 (Suppl):S63–S68. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dupont N, Chauhan S, Arko-Mensah J,
Castillo EF, Masedunskas A, Weigert R, Robenek H, Proikas-Cezanne T
and Deretic V: Neutral lipid stores and lipase PNPLA5 contribute to
autophagosome biogenesis. Curr Biol. 24:609–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Galluzzi L, Baehrecke EH, Ballabio A, Boya
P, Pedro JMB, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, et
al: Molecular definitions of autophagy and related processes. EMBO
J. 36:1811–1836. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liao CC, Ho MY, Liang SM and Liang CM:
Autophagic degradation of SQSTM1 inhibits ovarian cancer motility
by decreasing DICER1 and AGO2 to induce MIRLET7A-3P. Autophagy.
14:2065–2082. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rybstein MD, Bravo-San PJ, Kroemer G and
Galluzzi L: The autophagic network and cancer. Nat Cell Biol.
20:243–251. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Barlin JN, Yu C, Hill EK, Zivanovic O,
Kolev V, Levine DA, Sonoda Y, Abu-Rustum NR, Huh J, Barakat RR, et
al: Nomogram for predicting 5-year disease-specific mortality after
primary surgery for epithelial ovarian cancer. Gynecol Oncol.
125:25–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lee CK, Simes RJ, Brown C, Gebski V,
Pfisterer J, Swart AM, Berton-Rigaud D, Plante M, Skeie-Jensen T,
Vergote I, et al: A prognostic nomogram to predict overall survival
in patients with platinum-sensitive recurrent ovarian cancer. Ann
Oncol. 24:937–943. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu XL, Cheng H, Tang MS, Zhang HL, Wu RY,
Yu Y, Li X, Wang XM, Mai J, Yang CL, et al: A novel nomogram based
on LODDS to predict the prognosis of epithelial ovarian cancer.
Oncotarget. 8:8120–8130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bogani G, Tagliabue E, Ditto A, Signorelli
M, Martinelli F, Casarin J, Chiappa V, Dondi G, Maggiore ULR,
Scaffa C, et al: Assessing the risk of pelvic and para-aortic nodal
involvement in apparent early-stage ovarian cancer: A predictors-
and nomogram-based analyses. Gynecol Oncol. 147:61–65. 2017.
View Article : Google Scholar : PubMed/NCBI
|
